Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lassen

Showing results (131-140 of 135) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 135 results.
Scientific Reports|June 14, 2020
Remote ischemic conditioning in active ulcerative colitis: An explorative randomized clinical trialLine E Godskesen, Thomas R Lassen, Nichlas R Jespersen, et al.
Lancet (London, England)|May 5, 2009
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trialAlexander G G Turpie, Michael R Lassen, Bruce L Davidson, et al.
International Angiology : a Journal of the International Union of Angiology|February 16, 2008
Major joint replacement. A model for antithrombotic drug development: from proof-of-concept to clinical useO E Dahl, L C Borris, D Bergqvist, et al.
Thrombosis Research|July 21, 1998
Efficacy and safety of prolonged thromboprophylaxis with a low molecular weight heparin (dalteparin) after total hip arthroplasty--the Danish Prolonged Prophylaxis (DaPP) StudyM R Lassen, L C Borris, B S Anderson, et al.
International Angiology : a Journal of the International Union of Angiology|January 10, 2014
Prevention and treatment of venous thromboembolism--International Consensus StatementA N Nicolaides, J Fareed, A K Kakkar, et al.
Pageof 14

Showing results (131-140 of 135) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 135 results.
Scientific Reports|June 14, 2020
Remote ischemic conditioning in active ulcerative colitis: An explorative randomized clinical trialLine E Godskesen, Thomas R Lassen, Nichlas R Jespersen, et al.
Lancet (London, England)|May 5, 2009
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trialAlexander G G Turpie, Michael R Lassen, Bruce L Davidson, et al.
International Angiology : a Journal of the International Union of Angiology|February 16, 2008
Major joint replacement. A model for antithrombotic drug development: from proof-of-concept to clinical useO E Dahl, L C Borris, D Bergqvist, et al.
Thrombosis Research|July 21, 1998
Efficacy and safety of prolonged thromboprophylaxis with a low molecular weight heparin (dalteparin) after total hip arthroplasty--the Danish Prolonged Prophylaxis (DaPP) StudyM R Lassen, L C Borris, B S Anderson, et al.
International Angiology : a Journal of the International Union of Angiology|January 10, 2014
Prevention and treatment of venous thromboembolism--International Consensus StatementA N Nicolaides, J Fareed, A K Kakkar, et al.
Pageof 14